Cargando…

Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

After more than a century from its discovery, valproic acid (VPA) still represents one of the most efficient antiepi-leptic drugs (AEDs). Pre and post-synaptic effects of VPA depend on a very broad spectrum of actions, including the regu-lation of ionic currents and the facilitation of GABAergic ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romoli, Michele, Mazzocchetti, Petra, D’Alonzo, Renato, Siliquini, Sabrina, Rinaldi, Victoria Elisa, Verrotti, Alberto, Calabresi, Paolo, Costa, Cinzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052829/ https://www.ncbi.nlm.nih.gov/pubmed/30592252 http://dx.doi.org/10.2174/1570159X17666181227165722

Ejemplares similares

O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?
por: Romoli, Michele, et al.
Publicado: (2015)

Therapeutic Options for Childhood Absence Epilepsy
por: Rinaldi, Victoria Elisa, et al.
Publicado: (2021)

Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases
por: Costa, Cinzia, et al.
Publicado: (2022)

Approach to Neonates and Young Infants with Fever without a Source Who Are at Risk for Severe Bacterial Infection
por: Esposito, Susanna, et al.
Publicado: (2018)

Migraine and epilepsy: what value today?
por: Costa, Cinzia, et al.
Publicado: (2015)

Levodopa in Parkinson’s Disease: Current Status and Future Developments
por: Tambasco, Nicola, et al.
Publicado: (2018)

Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
por: Tozzi, Alessandro, et al.
Publicado: (2018)

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
por: Tambucci, Renato, et al.
Publicado: (2016)

Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy
por: DiFrancesco, Jacopo C., et al.
Publicado: (2022)

Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy
por: Imam, Syed F, et al.
Publicado: (2017)

Valproic acid for children below 2 years of age with epilepsy
por: Muthaffar, Osama Y., et al.
Publicado: (2021)

Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study
por: Maschio, Marta, et al.
Publicado: (2020)

Metabolically healthy and metabolically unhealthy obese children both have increased carotid intima-media thickness: a case control study
por: Farello, Giovanni, et al.
Publicado: (2018)

Focal Epilepsy Associated with Glioneuronal Tumors
por: Loiacono, Giulia, et al.
Publicado: (2011)

Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
por: Tseng, Yu-Lung, et al.
Publicado: (2014)

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
por: Eusebi, Paolo, et al.
Publicado: (2018)

Current Evidence of the Oncological Benefit-Risk Profile of Hormone Replacement Therapy
por: D’Alonzo, Marta, et al.
Publicado: (2019)

Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy
por: Lattanzi, Simona, et al.
Publicado: (2018)

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019)

The association between gastro-oesophageal reflux and migraine in the paediatric population: a multicentre case–control study
por: Lenglart, Léa, et al.
Publicado: (2022)

Evaluation of Cardiac Repolarization Indices in Epilepsy Patients Treated with Carbamazepine and Valproic Acid
por: Asoğlu, Ramazan, et al.
Publicado: (2020)

Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy
por: Fujimoto, Ayataka, et al.
Publicado: (2022)

Overexpression of Homer1b/c induces valproic acid resistance in epilepsy
por: Wang, Yan, et al.
Publicado: (2022)

Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives
por: Coppola, Giangennaro, et al.
Publicado: (2019)

P066. Migraine with aura in the locker room: 4 case reports
por: Bernetti, Laura, et al.
Publicado: (2015)

“Comorbidity” between epilepsy and headache/migraine: the other side of the same coin!
por: Striano, Pasquale, et al.
Publicado: (2011)

Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion
por: Eleftheriadou, Maria, et al.
Publicado: (2019)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

Current role of perampanel in pediatric epilepsy
por: De Liso, Paola, et al.
Publicado: (2017)

P070. A 2-year prospective evaluation study on onabotulinumtoxinA 155 U in chronic migraine
por: Negro, Andrea, et al.
Publicado: (2015)

O068. A 2 years prospective evaluation study on onabotulinumtoxinA 195 U in chronic migraine
por: Negro, Andrea, et al.
Publicado: (2015)

Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment
por: Zuberi, Nudrat A., et al.
Publicado: (2017)

Vibrotactile Sensory Substitution Elicits Feeling of Ownership of an Alien Hand
por: D’Alonzo, Marco, et al.
Publicado: (2012)

Machine-learning media bias
por: D’Alonzo, Samantha, et al.
Publicado: (2022)

Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience
por: Romozzi, Marina, et al.
Publicado: (2022)

Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system
por: Tozzi, Alessandro, et al.
Publicado: (2015)

Epilepsy and genetic in Rett syndrome: A review
por: Operto, Francesca Felicia, et al.
Publicado: (2019)

Diet in the Treatment of Epilepsy: What We Know So Far
por: Verrotti, Alberto, et al.
Publicado: (2020)

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Nakashima, Hiroo, et al.
Publicado: (2015)

MicroRNA-134 plasma levels before and after treatment with valproic acid for epilepsy patients
por: Wang, Xiaofeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_omem1fuqdqt8of6fgt4fh9ou86